Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.7050
+0.0098 (1.41%)
At close: May 29, 2026, 4:00 PM EDT
0.7153
+0.0103 (1.46%)
After-hours: May 29, 2026, 4:00 PM EDT

Pasithea Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
50.555.266.9216.3333.0952.97
Cash & Short-Term Investments
50.555.266.9216.3333.0952.97
Cash Growth
845.49%698.24%-57.61%-50.64%-37.53%-
Other Receivables
---0.04--
Total Trade Receivables
---0.04--
Other Current Assets
2.231.20.450.320.990.33
Total Current Assets
52.7356.467.3716.6934.0853.3
Net Property, Plant & Equipment
--0.120.220.630.02
Other Intangible Assets
3.623.787.317.948.57-
Goodwill
--1.261.261.26-
Other Long-Term Assets
----0.64-
Total Assets
56.3560.2416.0626.1245.1853.32
Accounts Payable
1.491.131.122.551.480.45
Current Portion of Leases
---0.080.16-
Other Current Liabilities
-3.84--0.24-
Total Current Liabilities
1.494.971.122.631.880.45
Long-Term Leases
----0.34-
Other Long-Term Liabilities
0.050.050.160.080.461.45
Total Long-Term Liabilities
0.050.050.160.080.81.45
Total Liabilities
1.545.021.282.722.681.9
Common Stock
000000.02
Additional Paid-in Capital
127.64125.2164.3758.7261.8653.63
Accumulated Other Comprehensive Income
0.050.02-0.01-0-0-0.01
Retained Earnings
-72.88-70.01-49.58-35.32-19.36-2.21
Shareholders' Equity
54.8155.2214.7823.442.551.42
Total Liabilities & Equity
56.3560.2416.0626.1245.1853.32
Total Debt
-000.080.50
Net Cash (Debt)
50.555.266.9216.2532.5852.97
Net Cash Growth
-8.61%698.24%-57.40%-50.13%-38.48%-
Net Cash Per Share
4.037.866.3213.2525.81101.81
Book Value
54.8155.2214.7823.442.551.42
Book Value Per Share
4.377.8513.4919.0833.6798.84
Tangible Book Value
51.1951.446.2114.1932.6651.42
Tangible Book Value Per Share
4.087.325.6611.5725.8898.84
Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q